“Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer”, Can Oncol Today, vol. 1, no. 3, pp. 10–16, Oct. 2024, doi: 10.58931/cot.2024.1326.